Welcome to our dedicated page for Ford Mtr Co Del SEC filings (Ticker: F), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
From F-150 trucks to Mustang Mach-E electric crossovers, Ford Motor Company鈥檚 diverse operations make each SEC report a roadmap to its next profit driver. If you鈥檝e ever wondered, 鈥淲here can I find the Ford Motor Company quarterly earnings report 10-Q filing?鈥� or needed Ford Motor Company insider trading Form 4 transactions at a glance, you鈥檙e in the right place.
Stock Titan transforms dense disclosures into plain language. Our AI turns every Ford Motor Company annual report 10-K simplified into a concise briefing, spotlighting warranty accrual shifts, union pension obligations, and Model e battery commitments. Receive Ford Motor Company earnings report filing analysis within minutes of EDGAR release, see Ford Motor Company proxy statement executive compensation broken down line-by-line, and get Ford Motor Company 8-K material events explained the day they land.
Whether you鈥檙e understanding Ford Motor Company SEC documents with AI or tracking Ford Motor Company Form 4 insider transactions real-time, Stock Titan keeps professionals ahead of the curve.
- AG真人官方-time alerts on Ford Motor Company executive stock transactions Form 4
- AI summaries for every Ford Motor Company SEC filings explained simply, including 10-Q, 10-K, and 8-K
- Historical search and trend charts covering decades of disclosures
UroGen Pharma Ltd. (URGN) submitted a Form 4 showing that Chief Executive Officer Elizabeth A. Barrett acquired 87,615 performance stock units (PSUs) on 07/28/2025. The PSUs were originally granted on 01/31/2024 and became earned when a company-level milestone was reached. Each PSU entitles the holder to one ordinary share once the units vest on 12/31/2025, contingent upon Barrett鈥檚 continued employment. The award carries a $0 exercise price and no shares were sold or otherwise disposed of in the filing.
Post-transaction, the CEO directly holds 87,615 derivative securities representing potential ordinary shares; no changes were reported in her non-derivative share ownership. While the filing signals management鈥檚 alignment with performance goals, it also introduces a future dilution overhang equivalent to the underlying shares when they convert.
Golden Matrix Group, Inc. (GMGI) 鈥� Form 144 filing
Anthony Brian Goodman has filed notice to sell 50,000 common shares through Oppenheimer & Co. on or after 28 Jul 2025. At the reference price disclosed, the sale represents an aggregate market value of $80,965 and equals roughly 0.036 % of the 138.39 million shares outstanding, indicating de-minimis dilution because the shares are already issued.
The filer previously sold 200,000 shares over the prior three months (four blocks of 50,000 on 30 Jun, 7 Jul, 14 Jul and 21 Jul 2025) for combined gross proceeds of 鈮�$341,235. The shares being sold were originally acquired on 16 Sep 2021 as compensation from the issuer; no cash consideration was paid at acquisition.
The filer certifies no knowledge of undisclosed material adverse information and makes the required 10b5-1 representation. No additional financial data or corporate guidance is included in this notice.
On 15 July 2025, reAlpha Tech Corp. (Nasdaq: AIRE) executed a Consent, Release and Waiver with Streeterville Capital, the holder of the Company鈥檚 14 Aug 2024 secured promissory note. Section 4(v) of the original Note Purchase Agreement limits lock-ups to 75 days, potentially conflicting with stand-still provisions required for reAlpha鈥檚 planned follow-on equity offering registered on Form S-1.
- Financing flexibility: The Waiver authorizes reAlpha to (i) forgo variable-rate financings for up to 12 months after the offering closes and (ii) avoid any equity financings for 60 days post-closing, each subject to customary exceptions.
- Default protection: Streeterville agrees that complying with these restrictions will not constitute a breach, Trigger Event or Event of Default under the note documents.
- Time-sensitive: The Waiver automatically lapses if the equity offering is not consummated by 31 July 2025.
The agreement removes an immediate covenant conflict and paves the way for capital raising, but temporarily limits alternative financing avenues. The full text is filed as Exhibit 10.1.
Redwire Corp (RDW) 鈥� Form 4 insider filing: Chief Accounting Officer Chris Edmunds reported an automatic share withholding transaction on 1 July 2025 related to the vesting of restricted stock units (Transaction Code F, tax liability settlement).
- Securities disposed: 1,298 common shares at the closing price of $15.31.
- Post-transaction ownership: Edmunds now holds 96,956 common shares directly.
- Nature of transaction: Withholding for taxes is generally considered non-discretionary and does not indicate a change in sentiment.
No derivative securities were involved, and no open-market purchases or sales were recorded. The size of the withholding represents a small fraction of the insider鈥檚 total ownership and is unlikely to be market-moving.
Ford Motor Company (NYSE: F) has filed a Form 144 indicating that insider Andrew Frick intends to sell up to 30,000 common shares through UBS Financial Services on or about 07-02-2025. The shares were acquired via RSU vesting on 03-04-2024. At the reference price used in the filing, the proposed sale is valued at $345,000, representing roughly 0.0008 % of Ford鈥檚 ~3.9 billion shares outstanding. The form also discloses that the same insider sold 30,000 shares on 07-01-2025 for $330,000. No other financial metrics or corporate developments are provided. While the dollar amount is immaterial to Ford鈥檚 market capitalization, Form 144 alerts investors to short-term insider selling activity, which some market participants track as a sentiment gauge.
Ford Motor Company (symbol: F) has filed a Form 144 indicating the proposed sale of 30,000 common shares under Rule 144 of the Securities Act of 1933. The shares will be sold through UBS Financial Services, Inc., 11 Madison Ave., New York, NY 10010, with an aggregate market value of $330,000. The approximate sale date disclosed is 07/01/2025, and the shares are to be listed on the NYSE.
The filing shows that the seller originally acquired the shares via three restricted-stock unit (RSU) vesting events on 03/02/2021 (5,424 shares), 03/04/2022 (13,949 shares) and 03/04/2024 (10,627 shares), matching the total of 30,000 shares to be sold. Ford鈥檚 total shares outstanding, as referenced in the filing, are 3,905,696,769; therefore, the proposed sale represents roughly 0.0008 % of shares outstanding鈥攁n immaterial fraction from a market-capitalization standpoint.
No prior sales were reported during the last three months, and no remarks or 10b5-1 plan adoption dates were disclosed. The filer has affirmed that he or she is not in possession of undisclosed material adverse information.
Investment take-away: While the notice signals insider intent to liquidate equity worth $330,000, the volume is negligible relative to Ford鈥檚 float and should not, by itself, influence the valuation or liquidity of Ford shares.
Bank of Nova Scotia (BNS) is marketing Autocallable Leveraged Index Return Notes庐 (LIRNs) linked to the Nasdaq-100 Index庐 with a scheduled maturity in July 2028. The $10 face-value notes feature a single observation date about one year after pricing. If on that date the Index closes at or above its starting level, the notes are automatically called for $11.00 per unit, delivering a 10% absolute return and terminating the investment early.
If not called, holders participate in Index appreciation at a leverage factor to be fixed between 140%-160%. For example, at the indicative midpoint of 150%, a 20% Index rise would generate a 30% note return. There is no upside cap other than the leverage multiple. However, principal is fully at risk: if the Ending Value falls below the Starting Value, investors are exposed to a 1-for-1 loss of principal, down to zero, because the threshold is set at 100% of the Starting Value.
All payments rely on the senior unsecured credit of BNS. The initial estimated value is projected between $9.26 and $9.56, below the $10 public offer price, reflecting a $0.20 underwriting discount and a $0.05 hedging-related charge. Minimum purchase is 100 units, and investors buying 鈮�300,000 units in household accounts receive a $0.05 price concession. The notes will not be listed, and BofA Securities (calculation agent) is under no obligation to provide secondary liquidity.
Key terms:
- Principal Amount: $10 per unit
- Term: ~3 years if not called
- Call Level: 100% of Starting Value (Observation Date ~July 2026)
- Call Amount: $11.00 (includes $1.00 premium, 10%)
- Participation Rate: 140%-160% (set on pricing date)
- Threshold & Downside: 100% 鈥� full downside exposure
- Issuer Credit: senior unsecured claim on BNS; not FDIC/CDIC insured
- Secondary Market: none expected; any repurchases at issuer/agent discretion
Risk highlights detailed in the term sheet include potential loss of entire principal, valuation below issue price due to internal funding rate, limited liquidity, tax uncertainties under U.S. and Canadian law, and conflicts of interest as BofA Securities acts as calculation agent and hedging counterparty.
The product suits investors who are moderately bullish on the Nasdaq-100 over the next 12 months, can tolerate full downside risk, and do not require interim income or liquidity. It is not appropriate for capital-preservation objectives.